Submitted:
29 July 2025
Posted:
31 July 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Background Knowledge
2.1. Parkinson’s Disease and Artistic Behavior
2.2. Feature Extraction from Handwriting and Drawing Tasks
- Entropy: Measures complexity or randomness of motion.
- Smoothness: Reflects the fluidity of movement; lower values suggest tremor or rigidity.
- Kurtosis: Captures the sharpness or flatness of motion peaks.
- Wave Energy: Represents the total signal energy during a stroke.
- Average Pressure: Measures the pen tip’s applied force.
- Average Speed: Reflects overall drawing velocity.
- Segment Length: Tracks the length of individual stroke segments.
2.3. Supervised Machine Learning
2.4. Large Language Models (LLMs)
2.5. Fuzzy Ontologies and Semantic Reasoning in Protégé
2.6. Evaluation Metrics and Statistical Testing
3. Related Work
3.1. Parkinson’s Disease and Artistic Behavior
3.2. Art and Other Neurodegenerative Diseases
3.3. Intelligent Systems and Ontologies in Neurodegenerative Disease Research
4. Materials and Methods
4.1. Datasets
4.2. Data Recording
4.2.1. Data Augmentation
4.2.2. Data Validation

4.3. ChatGPT

4.4. Fuzzy Ontology
4.4.1. FWP Wave
4.4.2. FSP SPIRAL
4.4.3. FSPHD SPIRAL
4.5. ML
5. Results
5.1. Dataset 1
5.1.1. Healthy vs. Parkinsonian: Feature Distribution and Separability
5.1.2. Model Performance Comparison (Dataset-1)
5.1.3. Summary Interpretation
5.2. Dataset-2
5.2.1. Comparative Analysis of Healthy vs. Parkinsonian Classification
5.2.2. Interpretation
5.3. Dataset 3
5.3.1. Analysis of Parkinsonian vs Healthy Using Spiral Drawing Test Data
5.3.2. Interpretation
6. Discussion

- Limited sample size: The real-world datasets used for training and evaluation were relatively small. Even with CTGAN-generated synthetic data, the training size may be insufficient to fully capture the variability present in Parkinsonian motor patterns. This can affect the generalizability of the ML models.
- Reliance on synthetic data: While CTGAN was used to generate high-quality synthetic samples, synthetic augmentation may not perfectly replicate the subtle nuances of true clinical data. This introduces potential bias in model learning.
- Ontology scalability: Fuzzy ontology models rely on manually defined rules and thresholds. These rules may not be scaled well to broader datasets or new feature sets without significant human tuning.
- LLM constraints: ChatGPT was used in a zero-shot mode, without clinical fine-tuning. As such, its performance may underestimate what could be achieved with domain-adapted large language models.
7. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AD | Alzheimer's Disease |
| ASD | Artificial Intelligence |
| ASD | Autism Spectrum Disorder |
| ChatGPT | Chat Generative Pre-Trained Transformer |
| CTGAN | Conditional Tabular Generative Adversarial Network |
| ECDF | Empirical Cumulative Distribution Function |
| FN | False Negative |
| FP | False Positive |
| FSP | Fuzzy Spiral Parkinson |
| FSPHD | Fuzzy Spiral Parkinson Hand drawn |
| FTD | Frontotemporal Dementia |
| FWP | Fuzzy Wave Parkinson |
| KDE | Kernel Density Estimate |
| LLM | Large Language Models |
| ML | Machine Learning |
| OWL | Web Ontology Language |
| PCA | Principal Component Analysis |
| PD | Parkinson's Disease |
| SHAP | SHapley Additive exPlanations |
| TN | True Negative |
| TP | True Positive |
| USMLE | United States Medical Licensing Examination |
| XAI | Explainable Artificial Intelligence |
Appendix A
| Method | Precision | Recall | F1-Score | Notes |
| Fuzzy Ontology | 0.72 | 0.75 | 0.74 | High interpretability, encoded expert knowledge |
| Random Forest ML | 0.77 | 0.77 | 0.77 | Best balance of precision/recall, supported by SHAP |
| ChatGPT Classifier | 0.77 | 0.77 | 0.77 | Comparable to ML; useful as baseline or triage tool |
| Method | Precision | Recall | F1-Score | |
| ML (Random Forest) | 0.75 | 0.73 | 0.73 | |
| Fuzzy Ontology | 0.71 | 0.63 | 0.67 | |
| ChatGPT-Based Classifier | 0.64 | 0.63 | 0.63 |
| Metric | Value |
| Precision | 0.91 |
| Recall | 0.91 |
| F1-Score | 0.91 |
| Method | Precision | Recall | F1-Score |
| Ontology-Based | 0.91 | 0.91 | 0.91 |
| ML-Based | 0.67 | 0.73 | 0.70 |
| ChatGPT Rules | 0.50 | 0.50 | 0.50 |
References
- W. Poewe et al., “Parkinson disease,” Nat Rev Dis Primers, vol. 3, no. 1, p. 17013, 2017. [CrossRef]
- L. M. Y. Acosta, “Creativity and neurological disease,” 2014, Current Medicine Group LLC 1. [CrossRef]
- H. Shimura, R. Tanaka, T. Urabe, S. Tanaka, and N. Hattori, “Art and Parkinson’s disease: A dramatic change in an artist’s style as an initial symptom,” J Neurol, vol. 259, no. 5, pp. 879–881, May 2012. [CrossRef]
- “Painting as an open window to brain disorders,” Journal of Neurology & Stroke, vol. 10, no. 3, pp. 101–103, Jun. 2020. [CrossRef]
- G. Kleiner-Fisman, S. E. Black, and A. E. Lang, “Neurodegenerative Disease and the Evolution of Art: The Effects of Presumed Corticobasal Degeneration in a Professional Artist,” 2002.
- M. F. Mendez, “Dementia as a window to the neurology of art,” Med Hypotheses, vol. 63, no. 1, pp. 1–7, 2004. [CrossRef]
- J. C. Mell, S. M. Howard, and B. L. Miller, “Art and the brain,” Neurology, vol. 60, no. 10, pp. 1707–1710, May 2003. [CrossRef]
- J. Bogousslavsky, “Creativity in Painting and Style in Brain-damaged Artists,” 2006. [CrossRef]
- J. Bogousslavsky, “Artistic creativity, style and brain disorders,” Eur Neurol, vol. 54, no. 2, pp. 103–111, Oct. 2005. [CrossRef]
- B. Piechowski-Jozwiak and J. Bogousslavsky, “Neurological diseases in famous painters,” in Progress in Brain Research, vol. 203, Elsevier B.V., 2013, pp. 255–275. [CrossRef]
- B. Piechowski-Jozwiak and J. Bogousslavsky, “Dementia and Change of Style: Willem de Kooning - Obliteration of Disease Patterns?,” 2018, S. Karger AG. [CrossRef]
- B. Piechowski-Jozwiak and J. Bogousslavsky, “Abstract Expressionists and Brain Disease,” 2018, S. Karger AG. [CrossRef]
- R. L. Solso, “Brain Activities in a Skilled versus a Novice Artist: An fMRI Study,” 2001.
- M. Pelowski, B. T. M. Spee, J. Arato, F. Dörflinger, T. Ishizu, and A. Richard, “Can we really ‘read’ art to see the changing brain? A review and empirical assessment of clinical case reports and published artworks for systematic evidence of quality and style changes linked to damage or neurodegenerative disease,” Dec. 01, 2022, Elsevier B.V. [CrossRef]
- H. Bäzner and C. Riederer, “Dystonia in Arts and Artists,” in Treatment of Dystonia, Cambridge University Press, 2018, pp. 92–96. [CrossRef]
- G. Kleiner-Fisman, S. E. Black, and A. E. Lang, “Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist,” Movement Disorders, vol. 18, no. 3, pp. 294–302, Mar. 2003. [CrossRef]
- C. Kotsavasiloglou, N. Kostikis, D. Hristu-Varsakelis, and M. Arnaoutoglou, “Machine learning-based classification of simple drawing movements in Parkinson’s disease,” Biomed Signal Process Control, vol. 31, pp. 174–180, Jan. 2017. [CrossRef]
- P. Zham, S. P. Arjunan, S. Raghav, and D. K. Kumar, “Efficacy of Guided Spiral Drawing in the Classification of Parkinson’s Disease,” IEEE J Biomed Health Inform, vol. 22, no. 5, pp. 1648–1652, Sep. 2018. [CrossRef]
- M. Gil-Martín, J. M. Montero, and R. San-Segundo, “Parkinson’s disease detection from drawing movements using convolutional neural networks,” Electronics (Switzerland), vol. 8, no. 8, Aug. 2019. [CrossRef]
- D. Impedovo and G. Pirlo, “Online Handwriting Analysis for the Assessment of Alzheimer?s Disease and Parkinson?s Disease: Overview and Experimental Investigation,” in Frontiers in Pattern Recognition and Artificial Intelligence, vol. Volume 5, in Series on Language Processing, Pattern Recognition, and Intelligent Systems, vol. Volume 5. , WORLD SCIENTIFIC, 2019, pp. 113–128. [CrossRef]
- D. Impedovo and G. Pirlo, “Dynamic Handwriting Analysis for the Assessment of Neurodegenerative Diseases: A Pattern Recognition Perspective,” IEEE Rev Biomed Eng, vol. 12, pp. 209–220, May 2018. [CrossRef]
- F. Doshi-Velez and B. Kim, “Towards A Rigorous Science of Interpretable Machine Learning,” Mar. 2017, [Online]. Available: http://arxiv.org/abs/1702.08608.
- E. Ray Dorsey et al., “Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016,” Lancet Neurol, vol. 17, no. 11, pp. 939–953, Nov. 2018. [CrossRef]
- A. Koletis, P. Bitilis, N. Zafeiropoulos, and K. Kotis, “Can Semantics Uncover Hidden Relations between Neurodegenerative Diseases and Artistic Behaviors?,” Apr. 01, 2023, MDPI. [CrossRef]
- J. Chandra et al., “Screening of parkinson’s disease using geometric features extracted from spiral drawings,” Brain Sci, vol. 11, no. 10, Oct. 2021. [CrossRef]
- J. Mei, C. Desrosiers, and J. Frasnelli, “Machine Learning for the Diagnosis of Parkinson’s Disease: A Review of Literature,” May 06, 2021, Frontiers Media S.A. [CrossRef]
- L. Breiman, “Random Forests,” 2001.
- F. Pedregosa FABIANPEDREGOSA et al., “Scikit-learn: Machine Learning in Python Gaël Varoquaux Bertrand Thirion Vincent Dubourg Alexandre Passos PEDREGOSA, VAROQUAUX, GRAMFORT ET AL. Matthieu Perrot,” 2011. [Online]. Available: http://scikit-learn.sourceforge.net.
- M. Sallam, “ChatGPT Utility in Healthcare Education, Research, and Practice: Systematic Review on the Promising Perspectives and Valid Concerns,” Mar. 01, 2023, MDPI. [CrossRef]
- F. Bobillo and U. Straccia, “Fuzzy ontology representation using OWL 2,” International Journal of Approximate Reasoning, vol. 52, no. 7, pp. 1073–1094, Oct. 2011. [CrossRef]
- P. Mitra and G. Wiederhold, “An Ontology-Composition Algebra,” in Handbook on Ontologies, S. Staab and R. Studer, Eds., Berlin, Heidelberg: Springer Berlin Heidelberg, 2004, pp. 93–113. [CrossRef]
- T. Saito and M. Rehmsmeier, “The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets,” PLoS One, vol. 10, no. 3, Mar. 2015. [CrossRef]
- R. Inzelberg, “The awakening of artistic creativity and Parkinson’s disease,” Behavioral Neuroscience, vol. 127, no. 2, pp. 256–261, Apr. 2013. [CrossRef]
- M. Canesi, M. L. Rusconi, F. Moroni, A. Ranghetti, E. Cereda, and G. Pezzoli, “Creative Thinking, Professional Artists, and Parkinson’s Disease,” J Parkinsons Dis, vol. 6, no. 1, pp. 239–246, Mar. 2016. [CrossRef]
- J. O. Lauring et al., “Parkinson’s disease and changes in the appreciation of art: A comparison of aesthetic and formal evaluations of paintings between PD patients and healthy controls,” Brain Cogn, vol. 136, Nov. 2019. [CrossRef]
- C. R. Harrison et al., “Profiles in paint: contrasting responses to a common artistic exercise by people with different dementias,” Arts Health, vol. 11, no. 1, pp. 79–86, Jan. 2019. [CrossRef]
- G. Kleiner-Fisman and A. E. Lang, “Insights into brain function through the examination of art: the in£uence of neurodegenerative diseases.”.
- A. Alexiou, M. Psiha, and P. Vlamos, “Towards an expert system for accurate diagnosis and progress monitoring of Parkinson’s disease,” Adv Exp Med Biol, vol. 822, pp. 151–164, 2015. [CrossRef]
- A. Alexiou, M. Psiha, and P. Vlamos, “IFIP AICT 382 - An Integrated Ontology-Based Model for the Early Diagnosis of Parkinson’s Disease,” 2012.
- F. Geser, K. A. Jellinger, L. Fellner, G. K. Wenning, D. Yilmazer-Hanke, and J. Haybaeck, “Emergent creativity in frontotemporal dementia,” Mar. 01, 2021, Springer. [CrossRef]
- F. Zekri, R. Bouaziz, and E. Turki, “A fuzzy-based ontology for Alzheimer’s disease decision support,” in IEEE International Conference on Fuzzy Systems, Institute of Electrical and Electronics Engineers Inc., Nov. 2015. [CrossRef]
- F. Zekri, R. Bouaziz, and E. Turki, “A fuzzy-based ontology for Alzheimer’s disease decision support.”.
- D. R. Castillo Salazar, L. Lanzarini, H. Gómez, S. P. Thirumuruganandham, and D. X. Castillo Salazar, “Ontological Model in the Identification of Emotional Aspects in Alzheimer Patients,” Healthcare (Switzerland), vol. 11, no. 10, May 2023. [CrossRef]
- A. Oluwafemi and I. A. Jimoh, “Expert System for Diagnosis Neurodegenerative Diseases Investigation on Smart Meters and Revenue Generated for a Year Using Eko Electricity Distribution Company of Nigeria as Case Study View project Expert System for Diagnosis Neurodegenerative Diseases,” 2015. [Online]. Available: www.ijcit.com694.
- G. A. Vouros, G. Bouchouras, P. Bitilis, and K. Kotis, “LLMs for the Engineering of a Parkinson Disease Monitoring and Alerting Ontology,” 2024. [Online]. Available: https://www.researchgate.net/publication/383431620.
- G. Bouchouras, G. Sofianidis, and K. Kotis, “Predicting Freezing of Gait in Parkinson’s Disease: A Machine Learning-Based Approach in ON and OFF Medication States,” J Clin Med, vol. 14, no. 6, Mar. 2025. [CrossRef]
- G. Bouchouras, G. Sofianidis, and K. Kotis, “Temporal Anomaly Detection in Attention-Deficit/Hyperactivity Disorder Using Recurrent Neural Networks,” Cureus, Dec. 2024. [CrossRef]
- G. Bouchouras and K. Kotis, “Integrating Artificial Intelligence, Internet of Things, and Sensor-Based Technologies: A Systematic Review of Methodologies in Autism Spectrum Disorder Detection,” Jan. 01, 2025, Multidisciplinary Digital Publishing Institute (MDPI). [CrossRef]
- P. Zham, D. K. Kumar, P. Dabnichki, S. P. Arjunan, and S. Raghav, “Distinguishing different stages of Parkinson’s disease using composite index of speed and pen-pressure of sketching a spiral,” Front Neurol, vol. 8, no. SEP, Sep. 2017. [CrossRef]
- M. Erdem Isenkul, B. Erdogdu Sakar, and B. Erdogdu Sakar Olcay Kursun, “Improved Spiral Test Using Digitized Graphics Tablet for Monitoring Parkinson’s Disease,” 2014. [CrossRef]
- B. E. Sakar et al., “Collection and analysis of a Parkinson speech dataset with multiple types of sound recordings,” IEEE J Biomed Health Inform, vol. 17, no. 4, pp. 828–834, 2013. [CrossRef]
- A. Rao, J. Kim, M. Kamineni, M. Pang, W. Lie, and M. D. Succi, “Evaluating ChatGPT as an Adjunct for Radiologic Decision-Making.,” medRxiv, Feb. 2023. [CrossRef]
- K. Singhal et al., “Large language models encode clinical knowledge,” Nature, vol. 620, no. 7972, pp. 172–180, Aug. 2023. [CrossRef]
- T. H. Kung et al., “Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models,” PLOS Digital Health, vol. 2, no. 2 February, Feb. 2023. [CrossRef]
- F. Bobillo and U. Straccia, “Reasoning within Fuzzy OWL 2 EL revisited,” Fuzzy Sets Syst, vol. 351, pp. 1–40, Nov. 2018. [CrossRef]
- W. Mckinney, “Data Structures for Statistical Computing in Python,” 2010.
- J. D. Hunter, “Matplotlib: A 2D Graphics Environment,” Comput Sci Eng, vol. 9, no. 3, pp. 90–95, 2007. [CrossRef]
- S. M. Lundberg and S.-I. Lee, “A Unified Approach to Interpreting Model Predictions,” in Advances in Neural Information Processing Systems, I. Guyon, U. Von Luxburg, S. Bengio, H. Wallach, R. Fergus, S. Vishwanathan, and R. Garnett, Eds., Curran Associates, Inc., 2017. [Online]. Available: https://proceedings.neurips.cc/paper_files/paper/2017/file/8a20a8621978632d76c43dfd28b67767-Paper.pdf.
- K. Białek, A. Potulska-Chromik, J. Jakubowski, M. Nojszewska, and A. Kostera-Pruszczyk, “Analysis of Handwriting for Recognition of Parkinson’s Disease: Current State and New Study,” Electronics (Switzerland), vol. 13, no. 19, Oct. 2024. [CrossRef]
- A. Holzinger, C. Biemann, D. Kell, C. S. Pattichis, and D. B. Kell, “What do we need to build explainable AI systems for the medical domain?,” 2017. [CrossRef]
- K. Singhal et al., “Large language models encode clinical knowledge,” Nature, vol. 620, no. 7972, pp. 172–180, Aug. 2023. [CrossRef]
- Y. Labrak, M. Rouvier, and R. Dufour, “A Zero-shot and Few-shot Study of Instruction-Finetuned Large Language Models Applied to Clinical and Biomedical Tasks,” Jun. 2024, [Online]. Available: http://arxiv.org/abs/2307.12114.
- R. Bommasani et al., “On the Opportunities and Risks of Foundation Models,” Jul. 2022, [Online]. Available: http://arxiv.org/abs/2108.07258.




Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).